MedPath

Comparing sedation effect of combination of ketamine with propofol and ketamine with dexmedetomidine in cases of upper GI endoscopy .

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2025/05/086887
Lead Sponsor
Peoples College of medical science and research center
Brief Summary

For this study elective  patients for Upper GI endoscopy will be divided in 2 groups for procedural sedation .1 group will be receiving intravenous ketamine with propofol for sedation and the 2nd group will be receiving  ketamine with dexmedetomidine for sedation .Both the groups will then be compared for haemodynamic changes - blood pressure and pulse and Ramsay sedation score and recovery time .ketamine will be the base drug and will be given in a dose of 1 mg/kg  .propofol will be given in a dose of 1 mg/kg  and  a maintenance dose of 0.25 mg/kg while  dexmedetomidine will be given in a dose of 0.5 mcg/ kg and a maintenance dose of 0.1 mcg/ kg .

In case adequate sedation is not achieved ketamine will be given in dose of 0.25 mg/ kg . Patients in both groups will also be assessed for recovery time along with Ramsay sedation score and haemodynamic changes.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

American society of Anaesthesiologist grade 1, 2 and 3 Patients for elective UGI Endoscopy.

Exclusion Criteria

Patients not giving consent ASA grade more than 3 Patients with cardiac risk Patients with shock Patients with severe hepatorenal impairment.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure variability20 minutes
Secondary Outcome Measures
NameTimeMethod
Sedation20 minutes

Trial Locations

Locations (1)

Peoples Hospital

🇮🇳

Bhopal, MADHYA PRADESH, India

Peoples Hospital
🇮🇳Bhopal, MADHYA PRADESH, India
Dr Catherine Singh
Principal investigator
09806543342
drcatherinesingh@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.